Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8713792 | Journal of Allergy and Clinical Immunology | 2018 | 29 Pages |
Abstract
Patients with clonal mast cell disease can present as having IA. Distinct clinical and laboratory features can be used to select those patients more likely to have an underlying clonal mast cell disorder (monoclonal mast cell activation syndrome or systemic mastocytosis) and thus candidates for a bone marrow biopsy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Melody C. MD, Avanti MSc, Hirsh D. MD, Yun MS, Sarah T. DO, Alicia S. BA, Karina N. BS, Lauren M. BSN, Daly MSN, Todd M. DO, Linda M. CRNP, Olga PhD, Mi-Yeon PhD, Jamie BS, Irina MD, Dean D. MD,